Author/Authors :
Eskandari Nasab، Ebrahim نويسنده Genetics of Non Communicable Disease Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran , , Kharazi-Nejad، Eslam نويسنده Department of Clinical Biochemistry, Faculty of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran. Kharazi-Nejad, Eslam , Nakhaee، Alireza نويسنده Department of Clinical Biochemistry, Cellular and Molecular Research Center, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Nakhaee, Alireza , Afzali، Masoumeh نويسنده Department of Clinical Biochemistry, Faculty of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran. Afzali, Masoumeh , Tabatabaei، Seyed Payman نويسنده Department of Cardiology, Faculty of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran. Tabatabaei, Seyed Payman , Tirgar-Fakheri، Kourosh نويسنده Department of Anesthesiology, Faculty of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran. Tirgar-Fakheri, Kourosh , Hashemi، Mohammad نويسنده ,
Abstract :
Compelling evidence suggests that the oxidative stress plays a key role in the pathophysiology of cardiovascular disease (CVD). Superoxide dismutase (SOD) enzymes play a major role in detoxification of reactive oxygen species and protection against oxidative stress. We examined the possible association between a 50-bp insertion/deletion in the SOD1 promoter 1684-bp upstream of the SOD1 ATG with CVD in an Iranian population. A total of 400 individuals including 200 CVD patients and 200 healthy subjects from the same ethnic background as the control group were participated in this study. Genomic DNA from all subjects was screened for the 50-bp SOD1 promoter deletion using a polymerase chain reaction (PCR) assay. Our finding showed an association between SOD1 DEL/DEL (9% vs. 2.5%) and INS/DEL genotypes and risk of CVD and these genotypes increased the susceptibility to CVD (OR=2.096, 95% CI: 1.336-3.286, P= 0.001 for the INS/DEL genotype; OR=4.811, 95% CI: 1.734-13.346, P= 0.003 for the DEL/DEL genotype). Additionally, the DEL allele of the SOD1 variation was found to be more prevalent in the CVD patients with the frequency of 26.3% and 13.5% in cases and controls, respectively, and this difference reached statistical significance (OR=2.281, 95% CI: 1.586-3.279, P= 0.001). The analysis of SOD1 genotypes according to patientsʹ characteristics revealed that the SOD1 Ins/del and Del/Del genotypes were more prevalent in CVD patients with a history of CVD or hypertension or DM (P<0.05), whereas the majority of Ins/Ins genotype carriers had no history of these diseases. Overall, our results demonstrated that SOD1 50-bp Del/Del and Ins/Del genotypes, as well as Del, allele, were associated with an increased risk of CVD.
